LY2599506

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Diabetes Mellitus, Type 2

Phase 2

A Study of LY2599506 in Patients With Type 2 Diabetes

TerminatedNCT01024244

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2009-12-31End: 2010-07-31Updated: 2011-12-02

A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus

TerminatedNCT01029795

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2010-02-28End: 2010-06-30Updated: 2011-12-02